Entera Bio Ltd. - Ordinary Shares, par value per share NIS 0.0000769 (ENTX)

CUSIP: M40527109

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+2,170,994
Put/Call ratio
0%
SEC-reported price per share
$2.12
Number of holders
14
Value change
+$4,661,706
Number of buys
7
Open additional details 1 more signal available
Number of sells
7
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
170,503,000

Security key

M40527109

Report period

Q4 2024

Institutions

14

Top holders

10

Ownership snapshot

Top reported holders of ENTX - Entera Bio Ltd. - Ordinary Shares, par value per share NIS 0.0000769 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Knoll Capital Management,...
Disclosed value leader
Knoll Capital Management,...
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F 3/4/5 Lead comparable stake: 2.3% Showing 1-6 of 15 holder rows.

Quick read

Knoll Capital Management, LLC leads the comparable SEC ownership view at 2.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Knoll Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Knoll Capital Management, LLC 2.3%
Schonfeld Strategic Advisors LLC 0.38%
Parkman Healthcare Partners LLC 0.24%
UBS Group AG 0.08%
RENAISSANCE TECHNOLOGIES LLC 0.04%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Knoll Capital Management, LLC
13F 3/4/5
Company · 10%+ Owner
2.3%
$7,375,570
3,881,879 shares
30 Sep 2024
Schonfeld Strategic Advisors LLC
13F
Company
13F
0.38%
$1,232,340
648,600 shares
30 Sep 2024
Parkman Healthcare Partners LLC
13F
Company
13F
0.24%
$781,044
411,076 shares
30 Sep 2024
UBS Group AG
13F
Company
13F
0.08%
$271,220
142,747 shares
30 Sep 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
0.04%
$116,280
61,200 shares
30 Sep 2024
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC
13F
Company
13F
0.03%
$89,923
47,328 shares
30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
7,494,222
Rows available
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q1 2026 Across Filers

Q1 2026 holders
26
Q4 2024 holders
14
Holder diff
-12
Investor Q1 2026 Shares Q4 2024 Shares Share Diff Share Chg % Q1 2026 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .